Effectiveness of Corticosteroid and 5% Dextrose Versus USG-guided Ozone Injections in Patients With Carpal Tunnel Syndrome: Three Blind Randomized Studies
Ozon treatment: Each patient will receive 2 ml 10 μg/ml ozon perineural injection into the median nerve under US guidance, for 1 session.
Steroid treatment: Each patient will receive 2 ml:(1 ml betamethasone dipropionate+1ml saline) perineural injection into the median nerve under US guidance, for 1 session.
Dextrose 5%: Each patient will receive 2 ml %5 dextrose perineural injection into the median nerve under US guidance, for 1 session.
Study summary
Effectiveness of corticosteroid and 5% dextrose versus USG-guided ozone injections in patients with carpal tunnel syndrome: Three blind randomized studies
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria:
* Being between 18-65 years old
* Have been clinically diagnosed with carpal tunnel syndrome
* Confirmation of moderate CTS diagnosis with EMG
* Having typical CTS symptoms for at least 3 months
* Not having benefited from splinting and rest
Exclusion Criteria:
* History of polyneuropathy, brachial plexopathy, thoracic outlet syndrome or wrist surgery
* History of inflammatory arthritis, hypothyroidism, pregnancy, rheumatologic disorders or pacemaker
* Current warfarin use, previous corticosteroid injection for CTS, trauma or neoplasm at the injection site, hypersensitivity to corticosteroids or skin infection(injection site)
* G6PD deficiency, hyperthyroidism, thrombocytopenia, severe cardiovascular instability and those receiving ACE inhibitors
Primary outcome measure(s)
Visual Analog Scale(VAS) — This evaluation will be made and recorded at the baseline, at the 4th, 12th and 24th weeks after the procedure. Global pain:The VAS used for pain assessment consists of a line drawn in the form a ruler,and numbers from 0 to 10(with 0 as ''no pain'' and 10 as ''unbearable pain'' ) were asked to score.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.